Table 2.

Late relapses: patient characterization and treatment at first relapse.

Patient	Age* years	CR1 duration years	Survival years		Treatment at 1st relapse	HSCT at CR2
			After relapse	Overall
1	62	3.1	8	11.1	Unknown	Unknown
2	45	4.1	14.3	18.4	ATRA + chemotherapy	Autologous
3	46	4.1	0.1b	4.2	ATRA + chemotherapy	No
4	38	4.0	13.4	17.4	ATRA + chemotherapy	No
5	62	3.3	0.1b	3.4	Chemotherapy	No
6	58	4.6	5.4	10	ATRA + chemotherapy	Allogeneic
7	15	3.8	12.8	16.6	Chemotherapy	Allogeneic
8	14	3.7	14.8	18.5	ATRA	Allogeneic
9c	16	3.9	13.1	17	IT chemotherapy ATRA + chemotherapy	Allogeneic

^*Age at diagnosis.

^bPatients who died after relapse.

^cIsolated CNS relapse; all other relapses were in the bone marrow.